Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

7.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.5K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.4K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.1K
Coagulation01:09

Coagulation

8.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.1K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

60
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
60

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of termination-of-resuscitation rules in foreign body airway obstruction-related out-of-hospital cardiac arrest: a prospective multicenter registry analysis.

Prehospital emergency care·2026
Same author

Determinants of bystander removal attempts in witnessed foreign body airway obstruction: a prospective nationwide multicenter observational study from the MOCHI registry.

Resuscitation plus·2026
Same author

Response to "comment on effectiveness of vacuum-assisted wound closure and mesh-mediated fascial traction in open abdomen management".

Surgery today·2026
Same author

Impact of physician shift work implementation on mortality and length of stay in an emergency and critical care center: an interrupted time series analysis.

BMC health services research·2026
Same author

Airway obstruction time and outcomes after foreign body airway obstruction: a nationwide prospective cohort study from the MOCHI registry.

Resuscitation·2026
Same author

Shunt-related internal carotid artery dissection during carotid endarterectomy: illustrative cases.

Journal of neurosurgery. Case lessons·2026

Related Experiment Video

Updated: Oct 17, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.6K

[Coagulation and Fibrinolytic Disorder].

Ryuta Nakae1

  • 1Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital.

No Shinkei Geka. Neurological Surgery
|October 7, 2021
PubMed
Summary

Traumatic brain injury (TBI) disrupts blood clotting and fibrinolysis. Early monitoring of coagulation and fibrinolytic parameters is crucial for managing TBI patients and improving outcomes.

Area of Science:

  • Neurotrauma
  • Hemostasis
  • Critical Care Medicine

Background:

  • Traumatic brain injury (TBI) is linked to complex coagulation and fibrinolytic disorders.
  • These disorders include consumptive coagulopathy, hyperfibrinolysis, and hypercoagulability following TBI.

Purpose of the Study:

  • To investigate the dynamic changes in coagulation and fibrinolytic parameters in the acute phase of TBI.
  • To highlight the prognostic significance of D-dimer and guide therapeutic interventions.

Main Methods:

  • Monitoring of coagulation parameters like Thrombin Antithrombin III complex and fibrinogen.
  • Assessment of fibrinolytic parameters including D-dimer and Plasminogen Activator Inhibitor-1.
  • Evaluation of clinical outcomes and response to interventions like tranexamic acid and fresh frozen plasma.

More Related Videos

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.1K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.0K

Related Experiment Videos

Last Updated: Oct 17, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.6K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.1K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.0K

Main Results:

  • Abnormal elevations in Thrombin Antithrombin III complex and D-dimer are observed early post-TBI.
  • Fibrinogen is rapidly consumed within 3 hours, while Plasminogen Activator Inhibitor-1 peaks at 6 hours.
  • High D-dimer levels correlate with a worse prognosis ('talk and deteriorate' phenomenon).

Conclusions:

  • Coagulation and fibrinolysis change dynamically in acute TBI, impacting patient outcomes.
  • Early administration of tranexamic acid may reduce TBI-related mortality.
  • Timely fresh frozen plasma transfusion with fibrinogen monitoring is recommended, avoiding excessive administration.